Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

During the Trading Day
8.75 +0.04 / +0.46%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.75 0.00 / 0.00%
Volume: 17.1K
Health Technology
Pharmaceuticals: Other

Company Description

Theravance, Inc. is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It engages in the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial infections and central nervous system/pain. The company was founded by P. Roy Vagelos, Mathai Mammen and George M. Whitesides in November 1996 and is headquartered in South San Francisco, CA.

Contact Information

Theravance, Inc.
901 Gateway Boulevard
South San Francisco California 94080
P:(650) 238-9640
Investor Relations:
(650) 808-4100



Other institutional46.36%
Mutual fund holders39.53%
Individual stakeholders37.65%

Top Executives

Michael W. AguiarPresident, Chief Executive Officer & Director
Eric d'EsparbesChief Financial Officer & Senior Vice President
Daniel M. CanafaxVice President-Clinical Development
Theodore L. WitekSenior Vice President-Clinical & Medical Affairs
Mike E. FaermChief Business Officer & Senior Vice President